US Patent 11117948 CD80 variant immunomodulatory proteins and uses thereof
Patent 11117948 was granted and assigned to ALPINE IMMUNE SCIENCES, INC. on September, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 28, 2021
Date of Patent
September 14, 2021
Patent Applicant
Patent Application Number
20210128
Patent Citations Received
Patent Jurisdiction
Patent Number
Find more entities like US Patent 11117948 CD80 variant immunomodulatory proteins and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.